cass commercial - CASS
CASS
Close Chg Chg %
57.67 -2.84 -4.92%
Closed Market
54.83
-2.84 (4.92%)
Volume: 117.41K
Last Updated:
Oct 23, 2026, 4:00 PM EDT
Company Overview: cass commercial - CASS
CASS Key Data
| Open $55.81 | Day Range 54.01 - 57.28 |
| 52 Week Range 38.43 - 59.63 | Market Cap $703.05M |
| Shares Outstanding 12.81M | Public Float 11.25M |
| Beta 0.40 | Rev. Per Employee N/A |
| P/E Ratio 19.80 | EPS $2.97 |
| Yield 221.95% | Dividend $0.34 |
| EX-DIVIDEND DATE Dec 4, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 75.51K |
CASS Performance
| 1 Week | 0.27% | ||
| 1 Month | 1.29% | ||
| 3 Months | 1.07% | ||
| 1 Year | 40.41% | ||
| 5 Years | 33.76% |
CASS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 59.50 | |
| Number of Ratings | 2 | Current Quarters Estimate | 0.80 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 2.965 | |
| Last Quarter’s Earnings | 0.81 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.46 | Next Fiscal Year Estimate | 3.60 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 2 | 2 | 2 |
| Mean Estimate | 0.80 | 0.81 | 2.97 | 3.60 |
| High Estimates | 0.84 | 0.85 | 3.00 | 3.65 |
| Low Estimate | 0.76 | 0.76 | 2.93 | 3.55 |
| Coefficient of Variance | 7.07 | 7.91 | 1.67 | 1.96 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 0 | 1 | 1 |
| HOLD | 2 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Cass Commercial - CASS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Cass Commercial - CASS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Joseph D. Rupp Director | 23,719 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 1,113,369.86 |
| Apr 28, 2026 | Franklin D. Wicks Director | 34,021 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 1,596,945.74 |
| Apr 28, 2026 | Benjamin Franklin Edwards Director | 29,604 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 1,389,611.76 |
| Apr 28, 2026 | Eric H. Brunngraber Executive Chairman; Director | 171,766 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 8,062,696.04 |
| Apr 28, 2026 | John Joseph Drabik Director | 1,704 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 79,985.76 |
| Apr 28, 2026 | Wendy J. Henry Director | 8,385 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 393,591.90 |
| Apr 28, 2026 | Robert A. Ebel Director | 26,973 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 1,266,112.62 |
| Apr 28, 2026 | Ann W. Marr Director | 8,460 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 397,112.40 |
| Apr 28, 2026 | Randall L. Schilling Director | 33,388 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $46.94 per share | 1,567,232.72 |
| Apr 22, 2026 | Sally H. Roth Director | 10,885 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $48.1 per share | 523,568.50 |
| Mar 24, 2026 | Ralph W. Clermont Director | 25,140 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $43.15 per share | 1,084,791.00 |
| Mar 24, 2026 | James J. Lindemann Director | 33,912 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $43.15 per share | 1,463,302.80 |
| Jan 30, 2026 | Michael J. Normile CFO | 17,835 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 789,198.75 |
| Jan 30, 2026 | Michael J. Normile CFO | 19,621 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 30, 2026 | Michael J. Normile CFO | 18,784 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 831,192.00 |
| Jan 30, 2026 | Dwight D. Erdbruegger President | 21,833 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 966,110.25 |
| Jan 30, 2026 | Dwight D. Erdbruegger President | 23,580 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 30, 2026 | Dwight D. Erdbruegger President | 22,945 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 1,015,316.25 |
| Jan 30, 2026 | Eric H. Brunngraber Executive Chairman; Director | 170,062 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 7,525,243.50 |
| Jan 30, 2026 | Eric H. Brunngraber Executive Chairman; Director | 173,938 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |